Holocene Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,161
Closed -$1.58M 783
2024
Q3
$1.58M Sell
10,161
-3,450
-25% -$515K 0.01% 569
2024
Q2
$1.86M Buy
+13,611
New +$1.86M 0.01% 534
2024
Q1
Sell
-62,324
Closed -$8.59M 747
2023
Q4
$8.59M Buy
62,324
+23,779
+62% +$3.13M 0.03% 267
2023
Q3
$4.7M Buy
+38,545
New +$5.14M 0.02% 397
2022
Q4
Sell
-22,463
Closed -$2.76M 735
2022
Q3
$2.76M Sell
22,463
-28,541
-56% -$3.76M 0.02% 359
2022
Q2
$6.78M Buy
51,004
+20,451
+67% +$2.79M 0.04% 288
2022
Q1
$4.18M Buy
+30,553
New +$4.26M 0.02% 315
2021
Q4
Sell
-13,908
Closed -$2.02M 884
2021
Q3
$2.02M Buy
+13,908
New +$2.03M 0.01% 546
2021
Q1
Sell
-6,588
Closed -$785K 822
2020
Q4
$785K Buy
+6,588
New +$803K 0.01% 586
2018
Q4
Sell
-3,648
Closed -$394K 681
2018
Q3
$394K Buy
+3,648
New +$400K 0.01% 596
2018
Q2
Sell
-2,305
Closed -$231K 600
2018
Q1
$231K Buy
+2,305
New +$236K 0.01% 488

Other funds holding DGX

Holocene Advisors's DGX Position: Q4 2024 in Review

Holocene Advisors sold out of Quest Diagnostics (DGX) in Q4 2024, closing a stake of 10,161 shares — an estimated $1.58M sold.

Holocene Advisors first reported a position in DGX in Q1 2018 and held it in 11 quarters. The position peaked at $8.59M in Q4 2023. 895 funds tracked by Wall St. Rank hold DGX as of Q4 2024.

  • Holocene Advisors reported no remaining Quest Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Holocene Advisors sold 10,161 Quest Diagnostics shares in Q4 2024, an estimated $1.58M.
  • Holocene Advisors first reported a position in Quest Diagnostics in Q1 2018 and held it in 11 quarters.
  • Holocene Advisors's Quest Diagnostics position peaked at $8.59M in Q4 2023.
  • 895 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.

Based on Holocene Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.